Table 5.
CMS V21 | DxCG Medicare | DxCG Medicaid | ||
---|---|---|---|---|
Prospective without Rx | Concurrent without Rx | Prospective with Rx | ||
2011 costs | ||||
Basic model | ||||
General | 0.2117 | 0.2228 | 0.2097 | 0.2487 |
Older | 0.1743 | 0.1771 | 0.1732 | 0.2538 |
MH‐SUD | 0.1819 | 0.1970 | 0.1873 | 0.2408 |
High cost | 0.0401 | 0.0676 | 0.0403 | 0.0949 |
Multimorbid | 0.1527 | 0.1690 | 0.1520 | 0.1903 |
Low risk | 0.0600 | 0.0684 | 0.0673 | 0.0470 |
Recalibrated with additional variables | ||||
General | 0.3485 | 0.3558 | 0.3485 | 0.3391 |
Older | 0.3428 | 0.3480 | 0.3440 | 0.3405 |
MH‐SUD | 0.3190 | 0.3252 | 0.3182 | 0.3148 |
High cost | 0.1423 | 0.1631 | 0.1434 | 0.1399 |
Multimorbid | 0.2640 | 0.2757 | 0.2631 | 0.2544 |
Low risk | 0.1321 | 0.1326 | 0.1319 | 0.1272 |
R 2 is based on square root OLS regression models.
All analyses are based on risk scores computed with 2010 clinical data in relation to 2011 costs.